Patents by Inventor Paul McGlynn

Paul McGlynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110250242
    Abstract: Compositions and methods for the prevention and/or treatment of airway and/or respiratory disorders are provided. The compositions comprise arformoterol (the (R,R)-formoterol isomer) and tiotropium.
    Type: Application
    Filed: October 22, 2009
    Publication date: October 13, 2011
    Applicant: SUNOVION PHARMACEUTICALS INC.
    Inventors: Holly Huang, Elizabeth B. Goodwin, Kendyl M. Schaefer, John P. Hanrahan, William T. Andrews, Paul Mcglynn
  • Publication number: 20100272654
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: July 9, 2010
    Publication date: October 28, 2010
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Publication number: 20100215589
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Application
    Filed: March 31, 2010
    Publication date: August 26, 2010
    Applicant: SEPRACOR INC.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Patent number: 7718822
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: May 18, 2010
    Assignee: Sepracor Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20090060917
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 5, 2009
    Applicant: Sepracor Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20090060922
    Abstract: The compound of formula (I) is a water-stable, long acting ?2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible obstructive airways diseases and the like.
    Type: Application
    Filed: August 22, 2008
    Publication date: March 5, 2009
    Applicant: Sepracor Inc.
    Inventors: Craig R. Abolin, H. Scott Wilkinson, Paul McGlynn, William K. McVicar
  • Publication number: 20080119564
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: August 8, 2007
    Publication date: May 22, 2008
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Publication number: 20070220571
    Abstract: A processor for a cable television set-top box has an interface for coupling the processor to a second processor. The processor also has a port that is coupleable to control a tuner, a demodulator and a DOCSIS module with or without DSG support. The tuner has an output coupled to the demodulator input, and the demodulator has an output to the DOCSIS module input. The demodulator's output is also coupled to a conditional access module controlled by the second processor. The processor issues commands via the port to control at least one of the tuner and the demodulator based on instructions received via the interface from the second processor.
    Type: Application
    Filed: February 26, 2007
    Publication date: September 20, 2007
    Applicant: Broadcom Corporation
    Inventors: Weimin Feng, Paul McGlynn, David Leo Lwin, David Martin Erickson, Haisong Wang
  • Patent number: 7256310
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: August 14, 2007
    Assignee: Sepracor Inc.
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge
  • Publication number: 20040115136
    Abstract: Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
    Type: Application
    Filed: December 8, 2003
    Publication date: June 17, 2004
    Inventors: Paul McGlynn, Roger Bakale, Craig Sturge